Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 13;11(14):7092–7109. doi: 10.7150/thno.58039

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

Comparison of the number of pre-, post-therapeutic and common NeoAgs. (A) The number of total, strong and weak NeoAgs before and after therapy; (B) the number of total pre- and post-therapeutic and common NeoAgs in patients with PR, SD and PD; (C) the number of unique pre- and post-therapeutic and common NeoAgs in patients with PR, SD and PD; (D) comparison of the percentage of common NeoAgs in patients with PR, SD and PD.